Literature DB >> 1964202

Rolipram, a phosphodiesterase inhibitor, in the treatment of two male patients with congenital nephrogenic diabetes insipidus.

D G Bichet, N Ruel, M F Arthus, M Lonergan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1964202     DOI： 10.1159/000186196

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  11 in total

1.  Targeting the Trafficking of Kidney Water Channels for Therapeutic Benefit.

Authors:  Pui W Cheung; Richard Bouley; Dennis Brown
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-09-27       Impact factor: 13.820

Review 2.  New insights into the dynamic regulation of water and acid-base balance by renal epithelial cells.

Authors:  Dennis Brown; Richard Bouley; Teodor G Păunescu; Sylvie Breton; Hua A J Lu
Journal:  Am J Physiol Cell Physiol       Date:  2012-03-28       Impact factor: 4.249

Review 3.  Bypassing vasopressin receptor signaling pathways in nephrogenic diabetes insipidus.

Authors:  Richard Bouley; Udo Hasler; Hua A J Lu; Paula Nunes; Dennis Brown
Journal:  Semin Nephrol       Date:  2008-05       Impact factor: 5.299

Review 4.  Urinary concentration: different ways to open and close the tap.

Authors:  Detlef Bockenhauer; Daniel G Bichet
Journal:  Pediatr Nephrol       Date:  2013-06-06       Impact factor: 3.714

Review 5.  Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.

Authors:  Hanne B Moeller; Søren Rittig; Robert A Fenton
Journal:  Endocr Rev       Date:  2013-01-29       Impact factor: 19.871

6.  High-throughput chemical screening identifies AG-490 as a stimulator of aquaporin 2 membrane expression and urine concentration.

Authors:  Naohiro Nomura; Paula Nunes; Richard Bouley; Anil V Nair; Stanley Shaw; Erica Ueda; Nutthapoom Pathomthongtaweechai; Hua A Jenny Lu; Dennis Brown
Journal:  Am J Physiol Cell Physiol       Date:  2014-06-18       Impact factor: 4.249

Review 7.  Cell culture models and animal models for studying the patho-physiological role of renal aquaporins.

Authors:  G Tamma; G Procino; M Svelto; G Valenti
Journal:  Cell Mol Life Sci       Date:  2011-12-22       Impact factor: 9.261

Review 8.  The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells-a Potential Target for Pharmacological Intervention in Cardiovascular Diseases.

Authors:  Tanja Vukićević; Maike Schulz; Dörte Faust; Enno Klussmann
Journal:  Front Pharmacol       Date:  2016-02-11       Impact factor: 5.810

9.  Roflumilast and aquaporin-2 regulation in rat renal inner medullary collecting duct.

Authors:  Ezigbobiara N Umejiego; Yanhua Wang; Mark A Knepper; Chung-Lin Chou
Journal:  Physiol Rep       Date:  2017-01

Review 10.  Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.

Authors:  Serena Milano; Monica Carmosino; Andrea Gerbino; Maria Svelto; Giuseppe Procino
Journal:  Int J Mol Sci       Date:  2017-11-10       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.